Vyome Holdings, Inc. (HIND)
1.80
+0.05
(+2.86%)
USD |
NASDAQ |
Oct 30, 16:00
1.78
-0.02
(-1.11%)
After-Hours: 20:00
Vyome Holdings Price to Book Value : 2.089 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 2.089 |
| October 29, 2026 | 2.031 |
| October 28, 2026 | 1.996 |
| October 27, 2026 | 1.973 |
| October 26, 2026 | 1.984 |
| October 23, 2026 | 2.077 |
| October 22, 2026 | 2.089 |
| October 21, 2026 | 2.135 |
| October 20, 2026 | 2.135 |
| October 19, 2026 | 2.135 |
| October 16, 2026 | 2.170 |
| October 15, 2026 | 2.216 |
| October 14, 2026 | 2.240 |
| October 13, 2026 | 2.286 |
| October 12, 2026 | 2.332 |
| October 09, 2026 | 2.425 |
| October 08, 2026 | 2.356 |
| October 07, 2026 | 2.367 |
| October 06, 2026 | 2.390 |
| October 05, 2026 | 2.240 |
| October 02, 2026 | 2.216 |
| October 01, 2026 | 2.228 |
| September 30, 2026 | 2.240 |
| September 29, 2026 | 2.344 |
| September 28, 2026 | 2.356 |
| Date | Value |
|---|---|
| September 25, 2026 | 2.367 |
| September 24, 2026 | 2.390 |
| September 23, 2026 | 2.332 |
| September 22, 2026 | 2.263 |
| September 21, 2026 | 2.240 |
| September 18, 2026 | 2.437 |
| September 17, 2026 | 2.274 |
| September 16, 2026 | 2.263 |
| September 15, 2026 | 2.332 |
| September 14, 2026 | 2.390 |
| September 11, 2026 | 2.390 |
| September 10, 2026 | 2.437 |
| September 09, 2026 | 2.390 |
| September 08, 2026 | 2.425 |
| September 04, 2026 | 2.576 |
| September 03, 2026 | 2.588 |
| September 02, 2026 | 2.530 |
| September 01, 2026 | 2.518 |
| August 31, 2026 | 2.507 |
| August 28, 2026 | 2.559 |
| August 27, 2026 | 2.564 |
| August 26, 2026 | 2.506 |
| August 25, 2026 | 2.588 |
| August 24, 2026 | 2.602 |
| August 21, 2026 | 2.611 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cardiac Biotech Solutions, Inc. | -- |
| Anika Therapeutics, Inc. | 2.042 |
| Enovis Corp. | 0.7773 |
| Edwards Lifesciences Corp. | 4.996 |
| Perspective Therapeutics, Inc. | 0.4051 |
Price to Book Value Related Metrics
| PS Ratio | 77.67 |
| Price to Free Cash Flow | 19.21 |
| Price | 1.80 |
| Earnings Yield | -194.8% |
| Market Cap | 12.63M |